Biomagnetics Net Income Applicable To Common Shares from 2010 to 2026
Biomagnetics Diagnos Net Loss yearly trend continues to be relatively stable with very little volatility. Net Loss is likely to drop to about -489.6 K. Net Loss is the net income that remains after preferred dividends have been deducted, available to common shareholders. View All Fundamentals
Check out the analysis of Biomagnetics Diagnos Correlation against competitors. To learn how to invest in Biomagnetics Stock, please use our How to Invest in Biomagnetics Diagnos guide.
Net Loss | First Reported 2010-12-31 | Previous Quarter -466.3 K | Current Value -489.6 K | Quarterly Volatility 99.9 K |
Check Biomagnetics Diagnos financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Biomagnetics Diagnos' main balance sheet or income statement drivers, such as Discontinued Operations of 0.0, Interest Expense of 0.0 or Selling General Administrative of 484.4 K, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 0.014. Biomagnetics financial statements analysis is a perfect complement when working with Biomagnetics Diagnos Valuation or Volatility modules.
Biomagnetics | Net Income Applicable To Common Shares | Build AI portfolio with Biomagnetics Stock |
Latest Biomagnetics Diagnos' Net Income Applicable To Common Shares Growth Pattern
Below is the plot of the Net Income Applicable To Common Shares of Biomagnetics Diagnos over the last few years. It is the net income that remains after preferred dividends have been deducted, available to common shareholders. Biomagnetics Diagnos' Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Biomagnetics Diagnos' overall financial position and show how it may be relating to other accounts over time.
| Net Income Applicable To Common Shares | 10 Years Trend |
|
Net Income Applicable To Common Shares |
| Timeline |
Biomagnetics Net Income Applicable To Common Shares Regression Statistics
| Arithmetic Mean | (522,504) | |
| Coefficient Of Variation | (19.12) | |
| Mean Deviation | 40,258 | |
| Median | (518,059) | |
| Standard Deviation | 99,911 | |
| Sample Variance | 10B | |
| Range | 537.4K | |
| R-Value | 0.18 | |
| Mean Square Error | 10.3B | |
| R-Squared | 0.03 | |
| Significance | 0.48 | |
| Slope | 3,654 | |
| Total Sum of Squares | 159.7B |
Biomagnetics Net Income Applicable To Common Shares History
About Biomagnetics Diagnos Financial Statements
Biomagnetics Diagnos shareholders use historical fundamental indicators, such as Net Income Applicable To Common Shares, to determine how well the company is positioned to perform in the future. Although Biomagnetics Diagnos investors may analyze each financial statement separately, they are all interrelated. The changes in Biomagnetics Diagnos' assets and liabilities, for example, are also reflected in the revenues and expenses on on Biomagnetics Diagnos' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Net Loss | -466.3 K | -489.6 K |
Pair Trading with Biomagnetics Diagnos
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Biomagnetics Diagnos position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biomagnetics Diagnos will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Biomagnetics Diagnos could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Biomagnetics Diagnos when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Biomagnetics Diagnos - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Biomagnetics Diagnos to buy it.
The correlation of Biomagnetics Diagnos is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Biomagnetics Diagnos moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Biomagnetics Diagnos moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Biomagnetics Diagnos can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Biomagnetics Stock Analysis
When running Biomagnetics Diagnos' price analysis, check to measure Biomagnetics Diagnos' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biomagnetics Diagnos is operating at the current time. Most of Biomagnetics Diagnos' value examination focuses on studying past and present price action to predict the probability of Biomagnetics Diagnos' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biomagnetics Diagnos' price. Additionally, you may evaluate how the addition of Biomagnetics Diagnos to your portfolios can decrease your overall portfolio volatility.